COMPANY PRESENTATION
Conference Call
9M 2025 Financial results
November 17th , 2025
2025 Financials - Euro '000
P&L | 30/09/2024 unaudited | % | 30/09/2025 unaudited | % | Var.% |
Revenues | 406.232 | 421.931 | 3,9% | ||
EBIT | 56.896 | 14,0% | 55.035 | 13,0% | -3,3% |
Revenues | 30/09/2024 | % | 30/09/2025 | % | Var.% |
Medical | 294.013 | 72,4% | 307.537 | 72,9% | 4,6% |
Industrial | 112.219 | 27,6% | 114.394 | 27,1% | 1,9% |
Euro '000 | 30/09/2024 unaudited | % | 30/09/2025 unaudited | % | Var. % |
Medical | 294.013 | 72,4% | 307.537 | 72,9% | 4,6% |
Industrial | 112.219 | 27,6% | 114.394 | 27,1% | 1,9% |
Revenues | 406.232 | 100,0% | 421.931 | 100,0% | 3,9% |
Gross margin | 176.928 | 43,6% | 188.342 | 44,6% | 6,5% |
Operating Expenses | 39.445 | 9,7% | 44.550 | 10,6% | 12,9% |
Staff espenses | 71.561 | 17,6% | 78.155 | 18,5% | 9,2% |
EBITDA | 65.922 | 16,2% | 65.637 | 15,6% | -0,4% |
Depr., amort., accruals | 9.025 | 2,2% | 10.602 | 2,5% | 17,5% |
EBIT | 56.896 | 14,0% | 55.035 | 13,0% | -3,3% |
Net financ.income(charges) | (693) | -0,2% | (1.778) | -0,4% | 156,5% |
Other income (expense) net | 5.024 | 1,2% | (1.078) | -0,3% | |
EBT | 61.228 | 15,1% | 52.180 | 12,4% | -14,8% |
31/12/24 | 30/09/25 | ||||
unaudited | |||||
Net financial position | 110.559 | 137.399 |
Euro '000 | 2024-Q3 unaudited | % | 2025-Q3 unaudited | % | Var. % |
Revenues | 134.761 | 100,0% | 136.595 | 100,0% | 1,4% |
Gross margin | 57.097 | 42,4% | 62.131 | 45,5% | 8,8% |
Operating Expenses | 11.327 | 8,4% | 13.607 | 10,0% | 20,1% |
Staff espenses | 23.227 | 17,2% | 25.110 | 18,4% | 8,1% |
EBITDA | 22.543 | 16,7% | 23.414 | 17,1% | 3,9% |
Depr., amort., accruals | 2.910 | 2,2% | 3.027 | 2,2% | 4,0% |
EBIT | 19.632 | 14,6% | 20.387 | 14,9% | 3,8% |
Net financ.income(charges) | (723) | -0,5% | 884 | 0,6% | |
Other income (expense) net | 24 | 0,0% | (817) | -0,6% | |
EBT | 18.933 | 14,0% | 20.454 | 15,0% | 8,0% |
20 mln
26 mln
13 mln
19 mln
* Nopat =Ebit-Income tax |
**D&A= Depreciation, Accruals and Devaluation |
***NWC= Net Working Capital |
+4%
Medical: +5%+8%
+4%
+5%
+2%
in Euro million
+2%
-22%
6% Industrial: +2%Medical: +5%
-1%
+9%
in Euro million
+27%
+6%
+12%
-10%
Industrial: +2% Revenues 2025 > Revenues 2024EBIT 2025 > EBIT 2024
CONTACTS
El.En. S.P.A.
Enrico Romagnoli
Investor Relations Manager
tel. +39 055-8826807
E-mail: finance@elen.it
POLYTEMS HIR
Financial Communication, IR and Press Office Bianca Fersini Mastelloni - b.fersini@polytemshir.it Silvia Marongiu - s.marongiu@polytemshir.it
Tel. +39 06-69923324
| Attention: This is an excerpt of the original content. To continue reading it, access the original document here. |